NATASHA AMY WATERLAND

Allopathic & Osteopathic Physicians|Internal Medicine COLUMBUS, OH NPI 1548759517

General Payments — all program years on this page

$486.15

  • Category: General Payments
  • Program years: PY2024
  • Record count: 22
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $486.15 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $486.1522

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2024 $486.1522

Records — PY2024 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078496528 Janssen Biotech, Inc. $22.59 11/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078497364 Janssen Biotech, Inc. $24.56 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087340347 Novartis Pharmaceuticals Corporation $27.56 11/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087340367 Novartis Pharmaceuticals Corporation $32.14 10/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087340375 Novartis Pharmaceuticals Corporation $26.19 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101167264 Celgene Corporation $15.50 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101646207 E.R. Squibb & Sons, L.L.C. $26.98 11/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114142779 Regeneron Healthcare Solutions, Inc. $14.98 10/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120866772 BeiGene USA, Inc. $15.74 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131889375 PFIZER INC. $16.50 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132134847 PFIZER INC. $22.56 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133078684 Genentech USA, Inc. $34.43 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133078687 Genentech USA, Inc. $13.94 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133078691 Genentech USA, Inc. $19.78 11/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134568183 Helsinn Therapeutics (U.S.), Inc. $13.21 10/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135238622 Lilly USA, LLC $24.50 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136189966 Organon Llc $28.93 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141158545 Fidia Pharma USA Inc. $14.64 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141644102 Merck Sharp & Dohme LLC $34.71 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141645679 Merck Sharp & Dohme LLC $22.34 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141645681 Merck Sharp & Dohme LLC $23.12 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145207265 Rigel Pharmaceuticals, Inc. $11.25 11/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.